Cargando…

Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins

Objective  This study was aimed to determine if different strategies of antenatal corticosteroid (ACS) administration in monoamniotic twins leads to receipt within 7 days of delivery. Study Design  This is a retrospective cohort of monoamniotic twins managed at a single institution from 2007 to 2017...

Descripción completa

Detalles Bibliográficos
Autores principales: Bibbo, Carolina, Easter, Sarah R., Saadeh, Michael, Little, Sarah E., Robinson, Julian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Thieme Medical Publishers 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491365/
https://www.ncbi.nlm.nih.gov/pubmed/31044097
http://dx.doi.org/10.1055/s-0039-1687872
_version_ 1783414919397376000
author Bibbo, Carolina
Easter, Sarah R.
Saadeh, Michael
Little, Sarah E.
Robinson, Julian N.
author_facet Bibbo, Carolina
Easter, Sarah R.
Saadeh, Michael
Little, Sarah E.
Robinson, Julian N.
author_sort Bibbo, Carolina
collection PubMed
description Objective  This study was aimed to determine if different strategies of antenatal corticosteroid (ACS) administration in monoamniotic twins leads to receipt within 7 days of delivery. Study Design  This is a retrospective cohort of monoamniotic twins managed at a single institution from 2007 to 2017. Patients were classified as to whether ACS were administered upon admission or at a predetermined gestational age (grouped together as “routine”) or for a change in clinical status (“indicated”). We used univariate analyses to associate ACS administration strategies with our primary outcome: receipt of ACS within 7 days of delivery. We then used generalized estimating equations to examine associations between fetal monitoring patterns and delivery within 1 week. Results  Twenty-four patients were included: eighteen patients in the “routine” group and six patients in the “indicated” group. There was no difference in optimal timing of ACS administration. Women experiencing delivery within the week were thrice more likely to spend on average more than 3 hours/day on the fetal monitor when compared with those who remained undelivered. Conclusion  Administration of ACS on admission is not effective. Fetal heart rate tracing surveillance might be a better methodology to predict delivery and guide ACS administration.
format Online
Article
Text
id pubmed-6491365
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Thieme Medical Publishers
record_format MEDLINE/PubMed
spelling pubmed-64913652019-05-01 Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins Bibbo, Carolina Easter, Sarah R. Saadeh, Michael Little, Sarah E. Robinson, Julian N. AJP Rep Objective  This study was aimed to determine if different strategies of antenatal corticosteroid (ACS) administration in monoamniotic twins leads to receipt within 7 days of delivery. Study Design  This is a retrospective cohort of monoamniotic twins managed at a single institution from 2007 to 2017. Patients were classified as to whether ACS were administered upon admission or at a predetermined gestational age (grouped together as “routine”) or for a change in clinical status (“indicated”). We used univariate analyses to associate ACS administration strategies with our primary outcome: receipt of ACS within 7 days of delivery. We then used generalized estimating equations to examine associations between fetal monitoring patterns and delivery within 1 week. Results  Twenty-four patients were included: eighteen patients in the “routine” group and six patients in the “indicated” group. There was no difference in optimal timing of ACS administration. Women experiencing delivery within the week were thrice more likely to spend on average more than 3 hours/day on the fetal monitor when compared with those who remained undelivered. Conclusion  Administration of ACS on admission is not effective. Fetal heart rate tracing surveillance might be a better methodology to predict delivery and guide ACS administration. Thieme Medical Publishers 2019-04 2019-04-30 /pmc/articles/PMC6491365/ /pubmed/31044097 http://dx.doi.org/10.1055/s-0039-1687872 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Bibbo, Carolina
Easter, Sarah R.
Saadeh, Michael
Little, Sarah E.
Robinson, Julian N.
Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title_full Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title_fullStr Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title_full_unstemmed Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title_short Timing of Antenatal Corticosteroid Administration in Monoamniotic Twins
title_sort timing of antenatal corticosteroid administration in monoamniotic twins
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491365/
https://www.ncbi.nlm.nih.gov/pubmed/31044097
http://dx.doi.org/10.1055/s-0039-1687872
work_keys_str_mv AT bibbocarolina timingofantenatalcorticosteroidadministrationinmonoamniotictwins
AT eastersarahr timingofantenatalcorticosteroidadministrationinmonoamniotictwins
AT saadehmichael timingofantenatalcorticosteroidadministrationinmonoamniotictwins
AT littlesarahe timingofantenatalcorticosteroidadministrationinmonoamniotictwins
AT robinsonjuliann timingofantenatalcorticosteroidadministrationinmonoamniotictwins